Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dodick

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Neurology|November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache|September 26, 2019
CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in miceEdita Navratilova, Jill Rau, Janice Oyarzo, et al.
Cephalalgia : an International Journal of Headache|October 27, 2010
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID studyRichard B Lipton, Stephen Silberstein, David Dodick, et al.
Journal of Medical Economics|March 25, 2018
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspectiveRichard B Lipton, Alan Brennan, Stephen Palmer, et al.
Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.
Headache|September 2, 2009
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measuresStephen Silberstein, Richard Lipton, David Dodick, et al.
Cephalalgia : an International Journal of Headache|May 22, 2016
Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodentsCaroline Machado Kopruszinski, Jennifer Yanhua Xie, Nathan Mackenzie Eyde, et al.
Brain and Behavior|September 22, 2018
Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based studyLise R Øie, Mattis A Madsbu, Ole Solheim, et al.
Cephalalgia : an International Journal of Headache|June 9, 2018
Vancouver Declaration on Global Headache Patient Advocacy 2018David Dodick, Lars Edvinsson, Tomohiko Makino, et al.
Cephalalgia : an International Journal of Headache|June 1, 2019
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraineMessoud Ashina, Peter J Goadsby, Uwe Reuter, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Neurology|November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache|September 26, 2019
CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in miceEdita Navratilova, Jill Rau, Janice Oyarzo, et al.
Cephalalgia : an International Journal of Headache|October 27, 2010
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID studyRichard B Lipton, Stephen Silberstein, David Dodick, et al.
Journal of Medical Economics|March 25, 2018
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspectiveRichard B Lipton, Alan Brennan, Stephen Palmer, et al.
Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.
Headache|September 2, 2009
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measuresStephen Silberstein, Richard Lipton, David Dodick, et al.
Cephalalgia : an International Journal of Headache|May 22, 2016
Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodentsCaroline Machado Kopruszinski, Jennifer Yanhua Xie, Nathan Mackenzie Eyde, et al.
Brain and Behavior|September 22, 2018
Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based studyLise R Øie, Mattis A Madsbu, Ole Solheim, et al.
Cephalalgia : an International Journal of Headache|June 9, 2018
Vancouver Declaration on Global Headache Patient Advocacy 2018David Dodick, Lars Edvinsson, Tomohiko Makino, et al.
Cephalalgia : an International Journal of Headache|June 1, 2019
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraineMessoud Ashina, Peter J Goadsby, Uwe Reuter, et al.
Pageof 7